
U.S. Pharmaceutical Preparation Market. Analysis And Forecast to 2030
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingRo and Eli Lilly Join Forces to Make Zepbound Vials Affordable
In a significant development, the direct-to-consumer health-care startup Ro has announced a new partnership with Eli Lilly to provide more affordable options for the weight loss drug Zepbound. According to CNBC, this platform will simplify access through a seamless integration with Eli Lilly's website, LillyDirect, thus consolidating services from diagnosis to home delivery.
As an initiative to make GLP-1 drugs more accessible, Ro will offer Zepbound in vial form at a lower cost than its more expensive autoinjector counterpart. These single-dose vials are priced at $399 for 2.5-milligram and $549 for 5-milligram doses, offering a considerable savings versus the $1,000 monthly cost of autoinjector pens. The initiative is part of Eli Lilly's efforts to streamline access to their products and potentially curb the rise of compounded versions of GLP-1 drugs.
In the broader context of pharmaceutical trade, the United States remains a key player in pharmaceutical preparations. According to data from the IndexBox platform, the export value of pharmaceutical preparations from the U.S. reached $43.4 billion in 2023. During the same period, the import value was notably higher at $105.6 billion, highlighting a significant trade gap.
This partnership between Ro and Eli Lilly signifies a noteworthy shift in the accessibility and affordability of vital medications, addressing chronic shortages in the U.S. By leveraging digital platforms and partnerships, both companies are poised to enhance the availability of effective weight loss treatments like Zepbound, ultimately benefiting consumers who are financially burdened by the high costs of such medications.
This report provides an in-depth analysis of the pharmaceutical preparation market in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- NAICS 325412 - Pharmaceutical preparation manufacturing
Companies mentioned:
- Pfizer Inc.
- Merck & Co.
- Abbott Laboratories
- Abbvie Inc.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Genentech
- Baxter International
- Allergan
- Biogen, Glaxosmithkline
- Celgene Corporation
- Hospira
- Alere
- Perrigo Company
- Mylan Inc.
- Regeneron Pharmaceuticals
- Novartis Corporation
- Alexion Pharmaceuticals
- Genzyme Corporation
- Zoetis
- Sanofi US Services
- Olympus Partners
- Valeant Pharmaceuticals International
- Merck Sharp & Dohme Corp.
- Glaxosmithkline Holdings (Americas)
- Wyeth
- Astrazeneca Pharmaceuticals
- Actavis Inc.
- Alcon Laboratories Holding Corporation
- Roche Holdings
Country coverage:
- United States
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the U.S.
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2024
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2024
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms, 2012–2024
- Market Value, 2012–2024
- Per Capita Consumption In 2012-2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country Of Origin, 2012–2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country Of Destination, 2012–2024
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2024
- Market Value, 2012–2024
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2024
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2024
- Trade Balance, In Physical Terms, 2012-2024
- Trade Balance, In Value Terms, 2012-2024
- Per Capita Consumption, 2012-2024
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2024
- Production, In Value Terms, 2012–2024
- Imports, In Physical Terms, 2012–2024
- Imports, In Value Terms, 2012–2024
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country Of Origin, 2012–2024
- Exports, In Physical Terms, 2012–2024
- Exports, In Value Terms, 2012–2024
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country Of Destination, 2012–2024